Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 32 peer-reviewed journal articles Updated
Cardiology · Heart Failure

What Causes Congestive Heart Failure? Can Treatment Help?

At a Glance

Treating the cause of congestive heart failure can sometimes improve heart function and symptoms, especially when the problem is found early and is reversible. Recovery depends on the cause, disease duration, and permanent heart scarring, and medicines often remain necessary.

In this answer

3 sections

01

Common Causes of Heart Failure

02

Can Treating the Cause Improve Heart Function?

03

Will I Still Need Heart Failure Medication?

Congestive heart failure (often simply called heart failure) happens when your heart cannot pump enough blood to meet your body’s needs, or when it becomes too stiff and fills at abnormally high pressures. This condition can develop gradually over time or occur abruptly (such as after a major heart attack or acute inflammation) [1]. Identifying and treating the specific cause of your heart failure is critical because it can stop further damage and, in many cases, help your heart function and symptoms improve [2]. However, whether your heart will recover depends heavily on the cause, how long you have had the condition, and whether irreversible scarring has occurred [3][4].

Safety Note: A newly diagnosed heart failure patient should seek emergency care for severe or rapidly worsening shortness of breath, chest pain, fainting, confusion, or blue lips. Contact your care team promptly for rapidly worsening swelling or sudden weight gain. This page is for education and does not replace individualized medical advice.

Common Causes of Heart Failure

Heart failure is often described by your ejection fraction—the percentage of blood the heart pumps out with each beat. The condition is broadly classified into categories like reduced ejection fraction (a weak squeeze), mildly reduced, preserved ejection fraction (a stiff heart that doesn’t fill well), or improved ejection fraction [1]. In any category, heart failure can be triggered by one or more of the following:

  • Coronary Artery Disease and Heart Attacks: This is a leading cause. Blocked arteries reduce blood flow to the heart. A major heart attack can cause sudden or permanent damage, leaving scar tissue that cannot pump [5].
  • High Blood Pressure (Hypertension): Long-standing high blood pressure forces the heart to work harder. Over time, the heart muscle can become abnormally thick and stiff, or eventually weaken [6].
  • Valve Disease: If the valves in your heart are narrowed (stenosis) or leak (regurgitation), the heart must pump harder to keep blood moving, which can eventually lead to heart failure [5][7].
  • Atrial Fibrillation and Rhythm Problems: A persistently rapid or irregular heartbeat (like atrial fibrillation) can cause or worsen heart failure (arrhythmia-induced cardiomyopathy). However, these rhythms can also be a consequence of heart failure rather than the primary cause [8][9].
  • Cardiomyopathy: This refers to diseases of the heart muscle itself. It can be inherited (genetic) or develop from events like late pregnancy (peripartum cardiomyopathy) [10][11].
  • Myocarditis: Inflammation of the heart muscle, often caused by a viral infection or an autoimmune condition, can suddenly weaken the heart [12][13].
  • Congenital Heart Disease: Heart defects present from birth can place extra strain on the heart throughout life [14].
  • Toxins and Medications: Heavy alcohol use or alcohol use disorder, recreational drugs like methamphetamine, and certain prescription medications (such as some chemotherapy drugs) can be toxic to the heart [15][16].
  • Infiltrative Conditions: Diseases like cardiac amyloidosis or sarcoidosis happen when abnormal proteins or inflammatory cells build up (infiltrate) the heart muscle, making it stiff [17][18].

Conditions like sleep apnea, diabetes, and chronic kidney disease can also heavily contribute to the development of heart failure [19]. Sometimes, multiple causes overlap. In other cases, no single cause is found despite testing, which doctors call idiopathic heart failure [20].

Can Treating the Cause Improve Heart Function?

Yes, in many situations, treating the underlying driver of your heart failure can lead to significant improvement in your heart’s function and your symptoms [2]. However, improvement is not always a complete “cure,” and the level of recovery varies. Examples include:

  • Restoring Blood Flow: For coronary artery disease, medications or procedures (like stents or bypass surgery) can restore blood flow to surviving heart muscle, preventing further damage, though it cannot reverse old scar tissue [21][22].
  • Controlling Heart Rhythm: Treating a rapid heartbeat with medications or a procedure called ablation can allow a weakened heart to recover its strength if the rhythm was the main cause [23][24]. (Stroke prevention is also a key part of this care).
  • Fixing Valves: Repairing or replacing a faulty valve reduces strain on the heart, often leading to improved function [25][26].
  • Removing Toxins: Stopping heavy alcohol use or harmful recreational drugs can sometimes allow the heart to heal. Safety Note: If you have an alcohol use disorder, seek medically supervised withdrawal. Never stop chemotherapy or prescribed medications without consulting your doctor [15][16].
  • Managing High Blood Pressure: Strict control prevents further damage and helps a stiff heart relax more effectively [6].

Shorter duration of heart failure and less structural damage generally mean a better chance for recovery [3][27].

Will I Still Need Heart Failure Medication?

Treating the cause complements, but does not replace, standard heart failure care. Even if treating the cause significantly improves your ejection fraction, you will likely need to stay on your heart failure medications [28].

Your exact medication plan is highly individualized based on your ejection fraction, cause, kidney function, and blood pressure. For many patients with a reduced ejection fraction, a specific combination of evidence-based medications protects the heart from further damage [29][30]. Research—particularly in patients with recovered dilated cardiomyopathy—shows that stopping these medications after heart function improves often causes heart failure to relapse [31]. Never change or stop your heart failure medications without your doctor’s guidance [32].

Common questions in this guide

What are the most common causes of congestive heart failure?
Common causes include coronary artery disease or a heart attack, long-term high blood pressure, heart valve disease, abnormal heart rhythms, and diseases of the heart muscle. Inflammation, congenital heart disease, toxic exposures, and conditions such as sleep apnea, diabetes, or chronic kidney disease can also contribute. Some people have more than one cause, and sometimes no single cause is found.
Can treating the cause of heart failure improve heart function?
Often, yes. Restoring blood flow, controlling a fast rhythm, repairing a faulty valve, managing blood pressure, or stopping harmful alcohol or drug exposure may improve the heart’s pumping ability and symptoms. Recovery is not guaranteed and depends on the cause, how long heart failure has been present, and whether permanent scar tissue remains.
Which types of heart failure may be partly reversible?
Heart failure caused mainly by a rapid rhythm, a treatable valve problem, reduced blood flow to living heart muscle, high blood pressure, or certain toxins may improve when the cause is addressed. Old scar tissue from a heart attack generally cannot be made to pump normally again. Doctors use the cause, imaging, and response to treatment to estimate recovery.
Do I still need heart failure medicine if my heart function improves?
Usually, yes. Heart failure medicines can help protect the heart and lower the risk that the condition will return, even when the ejection fraction improves. Do not reduce or stop them without your clinician’s guidance.
How do doctors determine what caused my heart failure?
Doctors combine your history and examination with an ECG, echocardiogram, blood tests, and sometimes cardiac MRI. They may also assess blood pressure, heart rhythm, kidney function, family history, sleep apnea, alcohol or drug exposure, and past chemotherapy. These findings help identify a treatable cause and signs of permanent damage.
When should heart failure symptoms be treated as an emergency?
Seek emergency care for severe or rapidly worsening shortness of breath, chest pain, fainting, confusion, or blue lips. Contact your care team promptly for rapidly worsening swelling or sudden weight gain. These symptoms can signal that your condition needs urgent assessment.

Related questions

Why Can Ejection Fraction Change Between Echocardiograms? Can You Stop Heart Failure Medications After EF Improves? What Do Heart Failure Stages and NYHA Classes Mean? What Are Target Doses for Heart Failure Medicines? What Do Orthopnea and PND Mean in Congestive Heart Failure?
Show more
Do SGLT2 Inhibitors Treat Heart Failure Without Diabetes? Which OTC Drugs and Supplements Are Unsafe in Heart Failure? How Are Low BP and Dizziness Managed in Heart Failure? Why Monitor Kidney Function and Potassium in Heart Failure? What Tests Are Used to Diagnose and Evaluate Heart Failure? How Do Loop Diuretics Work? Side Effects in Heart Failure Can You Have Heart Failure With a Normal Ejection Fraction? What If I Miss or Can't Afford Heart Failure Medicine? What Does Fluid Congestion Mean in Congestive Heart Failure? Can Congestive Heart Failure Be Cured or Reversed? How Do I Find My Dry Weight at Home With Heart Failure? What Heart Failure Medicine Side Effects Should I Report? Why Take Multiple Heart Failure Medicines If I Feel Better? Heart Failure vs Heart Attack vs Cardiac Arrest: Which One?

Get notified when new evidence is published on congestive heart failure.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (32)
  1. 1

    Phenomapping Heart Failure with Preserved Ejection Fraction Using Machine Learning Cluster Analysis: Prognostic and Therapeutic Implications.

    Galli E, Bourg C, Kosmala W, et al.

    Heart failure clinics 2021; (17(3)):499-518 doi:10.1016/j.hfc.2021.02.010.

    PMID: 34051979
  2. 2

    Factors Predicting Myocardial Recovery After Hospitalization for De Novo Heart Failure with Reduced Left Ventricular Ejection Fraction: Results from the COMFE Registry.

    Donoso-Trenado V, Otero-García Ó, López-Vilella R, et al.

    Biomedicines 2025; (13(5)) doi:10.3390/biomedicines13051143.

    PMID: 40426969
  3. 3

    Trajectories of Left Ventricular Ejection Fraction After Acute Decompensation for Systolic Heart Failure: Concomitant Echocardiographic and Systemic Changes, Predictors, and Impact on Clinical Outcomes.

    Albert J, Lezius S, Störk S, et al.

    Journal of the American Heart Association 2021; (10(3)):e017822 doi:10.1161/JAHA.120.017822.

    PMID: 33496189
  4. 4

    Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction.

    Perera D, Clayton T, O'Kane PD, et al.

    The New England journal of medicine 2022; (387(15)):1351-1360 doi:10.1056/NEJMoa2206606.

    PMID: 36027563
  5. 5

    Differences in clinical presentation between heart failure patients with reduced and preserved ejection fraction - analysis of the INTELHEART database.

    Belopavlović M, Rodić M, Stipić N, et al.

    Acta cardiologica 2026; (81(4)):579-588 doi:10.1080/00015385.2026.2677977.

    PMID: 42212486
  6. 6

    The Evolution from Hypertension to Heart Failure.

    Sorrentino MJ

    Heart failure clinics 2019; (15(4)):447-453 doi:10.1016/j.hfc.2019.06.005.

    PMID: 31472880
  7. 7

    Diastolic Dysfunction and Atrial Fibrillation: Recognition, Interplay, and Management.

    Hadid S, Hajj ME, Hadid B, et al.

    Cardiology in review 2026; (34(6)):508-512 doi:10.1097/CRD.0000000000000724.

    PMID: 38780254
  8. 8

    Managing Atrial Fibrillation in Patients With Heart Failure and Reduced Ejection Fraction: A Scientific Statement From the American Heart Association.

    Gopinathannair R, Chen LY, Chung MK, et al.

    Circulation. Arrhythmia and electrophysiology 2021; (14(6)):HAE0000000000000078 doi:10.1161/HAE.0000000000000078.

    PMID: 34129347
  9. 9

    Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review.

    Huizar JF, Ellenbogen KA, Tan AY, Kaszala K

    Journal of the American College of Cardiology 2019; (73(18)):2328-2344 doi:10.1016/j.jacc.2019.02.045.

    PMID: 31072578
  10. 10

    Myocardial tissue characterization by gadolinium-enhanced cardiac magnetic resonance imaging for risk stratification of adverse events in hypertrophic cardiomyopathy.

    Raiker N, Vullaganti S, Collins JD, et al.

    The international journal of cardiovascular imaging 2020; (36(6)):1147-1156 doi:10.1007/s10554-020-01808-6.

    PMID: 32166506
  11. 11

    Review of Randomized Controlled Trials in Patients with Peripartum Cardiomyopathy.

    Mujkanovic J, Qayyum AA

    Current cardiology reviews 2023; (19(2)):e230822207933 doi:10.2174/1573403X18666220823151854.

    PMID: 36017853
  12. 12

    Outcomes and predictors of recovery in acute-onset cardiomyopathy: A single-center experience of patients undergoing endomyocardial biopsy for new heart failure.

    Gilotra NA, Bennett MK, Shpigel A, et al.

    American heart journal 2016; (179()):116-26.

    PMID: 27595686
  13. 13

    Myocarditis in Patients With Antisynthetase Syndrome: Prevalence, Presentation, and Outcomes.

    Dieval C, Deligny C, Meyer A, et al.

    Medicine 2015; (94(26)):e798 doi:10.1097/MD.0000000000000798.

    PMID: 26131832
  14. 14

    Prognostic implications of heart failure rehospitalization in adults with CHD & clinical benefits of medical therapy.

    Rosado Rodriguez EP, Crowson CS, Egbe AC

    International journal of cardiology. Congenital heart disease 2025; (22()):100640 doi:10.1016/j.ijcchd.2025.100640.

    PMID: 41399644
  15. 15

    Comparison of Clinical Characteristics and Outcomes of Patients With Reversible Versus Persistent Methamphetamine-Associated Cardiomyopathy.

    Zhao SX, Seng S, Deluna A, et al.

    The American journal of cardiology 2020; (125(1)):127-134 doi:10.1016/j.amjcard.2019.09.030.

    PMID: 31699360
  16. 16

    Heart Failure With Reduced Ejection Fraction in a Patient With Erdheim-Chester Disease on Dabrafenib.

    Saenz-Ancira S, Higuera-Ornelas J, Bernades-Souza B, et al.

    JACC. Case reports 2024; (29(12)):102374 doi:10.1016/j.jaccas.2024.102374.

    PMID: 38808127
  17. 17

    Light-Chain (AL) Cardiac Amyloidosis Presenting as Heart Failure With Reduced Ejection Fraction.

    Santiago LE, Alvi AT, Melnychuk V, et al.

    Cureus 2024; (16(2)):e55271 doi:10.7759/cureus.55271.

    PMID: 38558722
  18. 18

    Cardiac Sarcoidosis.

    Birnie DH, Nery PB, Ha AC, Beanlands RS

    Journal of the American College of Cardiology 2016; (68(4)):411-21.

    PMID: 27443438
  19. 19

    Clinical Update in Heart Failure with Preserved Ejection Fraction.

    Krittanawong C, Britt WM, Rizwan A, et al.

    Current heart failure reports 2024; (21(5)):461-484 doi:10.1007/s11897-024-00679-5.

    PMID: 39225910
  20. 20

    Etiology of Heart Failure and Outcomes in Patients Hospitalized for Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction.

    Kajimoto K, Minami Y, Sato N, et al.

    The American journal of cardiology 2016; (118(12)):1881-1887 doi:10.1016/j.amjcard.2016.08.080.

    PMID: 27720439
  21. 21

    Survival Benefits of Invasive Versus Conservative Strategies in Heart Failure in Patients With Reduced Ejection Fraction and Coronary Artery Disease: A Meta-Analysis.

    Wolff G, Dimitroulis D, Andreotti F, et al.

    Circulation. Heart failure 2017; (10(1)) doi:10.1161/CIRCHEARTFAILURE.116.003255.

    PMID: 28087687
  22. 22

    Role of Coronary Revascularization in Patients with Ischemic Heart Disease and Heart Failure with Reduced Ejection Fraction.

    Lacalle M, Bazal P, García Ugalderbere J, et al.

    Journal of clinical medicine 2026; (15(5)) doi:10.3390/jcm15051941.

    PMID: 41827358
  23. 23

    Left ventricular wall thickness and functional recovery after atrial fibrillation ablation in patients with systolic dysfunction.

    Okada M, Tanaka N, Koyama Y, et al.

    Heart rhythm O2 2026; (7(9)):1656-1666 doi:10.1016/j.hroo.2026.06.009.

    PMID: 42774657
  24. 24

    Regression of Diffuse Ventricular Fibrosis Following Restoration of Sinus Rhythm With Catheter Ablation in Patients With Atrial Fibrillation and Systolic Dysfunction: A Substudy of the CAMERA MRI Trial.

    Prabhu S, Costello BT, Taylor AJ, et al.

    JACC. Clinical electrophysiology 2018; (4(8)):999-1007 doi:10.1016/j.jacep.2018.04.013.

    PMID: 30139501
  25. 25

    Transcatheter Mitral-Valve Repair in Patients with Heart Failure.

    Stone GW, Lindenfeld J, Abraham WT, et al.

    The New England journal of medicine 2018; (379(24)):2307-2318 doi:10.1056/NEJMoa1806640.

    PMID: 30280640
  26. 26

    2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures.

    Kittleson MM, Breathett K, Ziaeian B, et al.

    Circulation. Cardiovascular quality and outcomes 2024; (17(9)):e000132 doi:10.1161/HCQ.0000000000000132.

    PMID: 39116212
  27. 27

    Atrial Fibrillation-Mediated Cardiomyopathy.

    Qin D, Mansour MC, Ruskin JN, Heist EK

    Circulation. Arrhythmia and electrophysiology 2019; (12(12)):e007809 doi:10.1161/CIRCEP.119.007809.

    PMID: 31826649
  28. 28

    Heart failure with reduced ejection fraction.

    Cannata A, Crespo-Leiro MG, Bromage DI, et al.

    Lancet (London, England) 2026; (407(10527)):529-542 doi:10.1016/S0140-6736(25)01851-3.

    PMID: 41319669
  29. 29

    Misconceptions and Facts about Heart Failure with Reduced Ejection Fraction.

    Krittanawong C, Rodriguez M, Lui M, et al.

    The American journal of medicine 2023; (136(5)):422-431 doi:10.1016/j.amjmed.2023.01.024.

    PMID: 36740210
  30. 30

    Guidelines for treating heart failure.

    Kittleson MM

    Trends in cardiovascular medicine 2025; (35(3)):141-150 doi:10.1016/j.tcm.2024.10.002.

    PMID: 39442740
  31. 31

    Withdrawal versus continuation of guideline-directed medical therapy in heart failure with improved ejection fraction: a systematic review and meta-analysis.

    Jaramillo JCH, Muñoz JES, Arroyo MCO, et al.

    Romanian journal of internal medicine = Revue roumaine de medecine interne 2026; (64(3)):173-182 doi:10.2478/rjim-2026-0015.

    PMID: 42487279
  32. 32

    Heart Failure With Recovered Ejection Fraction in Patients With Nonischemic Cardiomyopathy: Characteristics, Outcomes, and Long-term Follow-up.

    Hammer Y, Yosef M, Khalatbari S, Aaronson KD

    Journal of cardiac failure 2023; (29(12)):1593-1602 doi:10.1016/j.cardfail.2023.06.022.

    PMID: 37451602

This page is for informational purposes only and does not constitute medical advice. Ask your clinician or cardiology team to interpret your cause, recovery prospects, and medicines, and seek emergency care for severe or rapidly worsening symptoms.